Tech Mahindra Ltd.

Tech Mahindra has started a coronavirus screening service 'Mhealthy', which can also detect COVID-19 antibodies. The platform is clinically tested and compliant with all government-mandated regulations, guidelines, and has been approved by the Central Drugs Standard Control Organisation.

Mhealthy not only does an instant risk assessment on COVID-19, but also additionally screens multiple factors that may contribute to risk. The Mhealthy service comprises over 32 screening tests on a single platform and detects antibodies with 96 per cent accuracy. The Mhealthy platform will categorise individuals opting for the screening as L1, L2 and L3. L1 means that the person is healthy. L2 means the person has had some exposure. If the person is L3 then the person is most likely to be a COVID-19-positive case.

Tech Mahindra represents the connected world, offering innovative and customer-centric information technology experiences, enabling Enterprises, Associates and the Society to Rise.